|
|
Volumn 22, Issue 2, 2003, Pages 383-389
|
|
Evaluation of the chemosensitivity of head and neck cancer cells based on the diverse function of mutated-p53.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
APOPTOSIS REGULATORY PROTEIN;
BAX PROTEIN, HUMAN;
BBC3 PROTEIN, HUMAN;
CDKN1A PROTEIN, HUMAN;
CYCLIN DEPENDENT KINASE INHIBITOR 1A;
CYCLINE;
DNA;
HYBRID PROTEIN;
LUCIFERASE;
MDM2 PROTEIN, HUMAN;
NUCLEAR PROTEIN;
ONCOPROTEIN;
P53AIP1 PROTEIN, HUMAN;
PROTEIN;
PROTEIN BAX;
PROTEIN BCL 2;
PROTEIN MDM2;
PROTEIN P53;
TUMOR PROTEIN;
AMINO ACID SUBSTITUTION;
APOPTOSIS;
ARTICLE;
BIOSYNTHESIS;
CELL CULTURE;
CELL TRANSFORMATION;
CODON;
COMPARATIVE STUDY;
DISEASE COURSE;
DNA DAMAGE;
DRUG EFFECT;
DRUG RESISTANCE;
GENETIC TRANSFECTION;
GENETICS;
HEAD AND NECK TUMOR;
HUMAN;
MISSENSE MUTATION;
PATHOLOGY;
PHYSIOLOGY;
POINT MUTATION;
REPORTER GENE;
SQUAMOUS CELL CARCINOMA;
TUMOR SUPPRESSOR GENE;
AMINO ACID SUBSTITUTION;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
APOPTOSIS REGULATORY PROTEINS;
BCL-2-ASSOCIATED X PROTEIN;
CARCINOMA, SQUAMOUS CELL;
CELL TRANSFORMATION, NEOPLASTIC;
CODON;
CYCLIN-DEPENDENT KINASE INHIBITOR P21;
CYCLINS;
DISEASE PROGRESSION;
DNA DAMAGE;
DNA, NEOPLASM;
DRUG RESISTANCE, NEOPLASM;
GENES, P53;
GENES, REPORTER;
HEAD AND NECK NEOPLASMS;
HUMANS;
LUCIFERASES;
MUTATION, MISSENSE;
NEOPLASM PROTEINS;
NUCLEAR PROTEINS;
POINT MUTATION;
PROTEINS;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-BCL-2;
PROTO-ONCOGENE PROTEINS C-MDM2;
RECOMBINANT FUSION PROTEINS;
TRANSFECTION;
TUMOR CELLS, CULTURED;
TUMOR SUPPRESSOR PROTEIN P53;
MLCS;
MLOWN;
|
|
EID: 0042161912
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.22.2.383 Document Type: Article |
|
Times cited : (13)
|
|
References (0)
|
